JiaLiang Medical Showcases Innovations at INS Interim Meeting in Almaty, Bridging Neuromodulation and Brain-Computer Interfaces
GenLight
Innovative Medical Device Solution Provider
From October 2 to 4, 2025, the International Neuromodulation Society Interim Meeting (INS Interim Meeting) will be grandly held in Almaty, Kazakhstan.
This conference brought together top neurosurgical experts and researchers from the United States, Europe, and Asia to discuss the latest breakthroughs and future trends in neuromodulation technology. On this high-level international academic platform, Genlight Neurotech, along with several neurosurgical experts in China, made a remarkable appearance, showcasing multiple cutting-edge application achievements. Through in-depth exchanges with the international academic community, the company demonstrated its innovative strength and global vision in the field of neuromodulation.
Cutting-edge Technology, Leading the Trend
At the conference exhibition area, Genlight Neurotech presented its independently developed Epilcure™ Implantable Closed-Loop Self-Responsive Neurostimulation System, LaserRO™ MRI-Guided Laser Ablation Minimally Invasive Surgical System, and S-Deep™ Intracranial Deep Electrodes, among other innovative products.
Authoritative Voice, Insight into the Future
During the conference, the expert panel specially invited by Genlight Neurotech became a major highlight. Several renowned experts in China shared their respective centers' clinical experiences and research progress at the "From Neuromodulation to Brain-Computer Interface" thematic forum.
Professor Yu Tao from Xuanwu Hospital, Capital Medical University"From Neuromodulation to Brain-Computer Interface (BCI): Experience Sharing from Xuanwu Hospital" systematically shared the development process of brain-computer interface technology and the practical experience of Xuanwu Hospital.
Professor Zhang Xin from Huashan Hospital, Fudan UniversityBrought the report "From Neuromodulation to Brain-Computer Interface (BCI): Huashan Hospital Experience Sharing," outlining the team's unique clinical translation pathway in this field.
Professor Song Shiwei from Fujian Medical University Union HospitalBrings the topic "Exploring the Parahippocampal Gyrus as a New Target for Responsive Neurostimulation in Medial Temporal Lobe Epilepsy".
Professor Zhu Junming from the Second Affiliated Hospital of Zhejiang University School of MedicineReported "Epidural Electrical Stimulation for the Recovery of Lower Limb Motor Function After Paraplegia," showcasing the team's cutting-edge exploration in spinal cord injury rehabilitation.
From the rapid advancement of BCI clinical practice to the exploration of new targets for epilepsy treatment, and to the groundbreaking attempts in spinal cord injury rehabilitation, this special session not only highlights the cutting-edge work of Chinese scholars in the field of neuromodulation but also offers new perspectives for international peers. As neuromodulation and brain-computer interface technologies rapidly merge, their clinical applications are moving from laboratories into the real world. It is foreseeable that brain-computer interface neuromodulation technology will play an increasingly vital role in treating neurological disorders such as epilepsy, movement disorders, spinal cord injuries, and mental health conditions.
Deepening Innovation, Connecting Globally
Genlight Neurotech's appearance this time not only showcased its product and technical strength but also further emphasized the company's "A vivid interpretation of the "Rooted in China, Serving the World" strategy. INS President Professor Slavin expressed high appreciation and gratitude for the successful hosting of the GenLight专场. He pointed out that GenLight Neurotech's active integration into international academic platforms and communication of China's voice is of great significance. He looks forward to further deepening cooperation between both parties in the future. Professor Slavin also stated that the International Neuromodulation Society will continue to support GenLight Neurotech, assisting in connecting with a broader range of international clinical and research expert resources, jointly promoting its innovative products globally to benefit more patients.。
2025.10.5
Kazakhstan · Almaty
